Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor

This article has been updated

Abstract

Background. A 33-year-old woman presented to an endocrinology clinic with a 5-year history of secondary amenorrhea. 2 years before presentation, she had noticed progressively worsening signs of virilization.

Investigations. Measurement of levels of serum free and total testosterone, androstenedione, dehydroepiandrosterone sulfate and gonadotropins; transvaginal ultrasonography, abdominal and pelvic MRI and 18F-fluorodeoxyglucose PET imaging.

Diagnosis. Virilization secondary to an ovarian Leydig cell tumor.

Management. The patient underwent a left salpingo-oophorectomy that confirmed the diagnosis of a unilateral Leydig cell tumor. Complete normalization of androgens and gonadotropin levels was achieved after surgery.

This is a preview of subscription content, access via your institution

Access options

Figure 1
Figure 2
Figure 3
Figure 4: Morphological and immunohistochemical studies performed on the ovarian Leydig cell tumor specimen.

Change history

  • 15 February 2011

    In the version of this article initially published online, there was an error in the legend of Figure 4. The magnification of Figure 4a should have read 200× instead of 20× and the magnification of Figure 4b should have read 400× instead of 40×. The error has been corrected in all electronic versions of the text

References

  1. Young, R. H. & Scully, R. E. Fibromatosis and massive edema of the ovary, possibly related entities: a report of 14 cases of fibromatosis and 11 cases of massive edema. Int. J. Gynecol. Pathol. 3, 153–178 (1984).

    Article  CAS  Google Scholar 

  2. Carmina, E., Rosato, F., Jannì, A., Rizzo, M. & Longo, R. A. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J. Clin. Endocrinol. Metab. 91, 2–6 (2006).

    Article  CAS  Google Scholar 

  3. Koonings, P. P., Campbell, K., Mishell Jr. D. R. & Grimes, D. A. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet. Gynecol. 74, 921–926 (1989).

    CAS  PubMed  Google Scholar 

  4. Martin, K. A. et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. Clin. Endocrinol. Metab. 93, 1105–1120 (2008).

    Article  CAS  Google Scholar 

  5. Meldrum, D. R. & Abraham, G. E. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet. Gynecol. 53, 36–43 (1979).

    CAS  PubMed  Google Scholar 

  6. Surrey, E. S., de Ziegler, D., Gambone, J. C. & Judd, H. L. Preoperative localization of androgen-secreting tumors: clinical, endocrinologic, and radiologic evaluation of ten patients. Am. J. Obstet. Gynecol. 158, 1313–1322 (1988).

    Article  CAS  Google Scholar 

  7. Waggoner W., Boots L. R. & Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol. Endocrinol. 13, 394–400 (1999).

    Article  CAS  Google Scholar 

  8. Pugeat, M., Mirakian, P., Dutrieux-Berger, N., Forest, M. G. & Tourniaire, J. in Androgen excess disorders in women (eds Azziz, R., Nestler, J. E. & Dewailly, D.) 555–568 (Lippincott-Raven, Philadelphia, 1997).

  9. Kaltsas, G. A. et al. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J. Clin. Endocrinol. Metab. 88, 2634–2643 (2003).

    Article  CAS  Google Scholar 

  10. Shenker, Y., Malozowski, S. N., Ayers, J., Grekin, R. J. & Barkan, A. L. Steroid secretion by a virilizing lipoid cell ovarian tumor: origins of dehydroepiandrosterone sulfate. Obstet. Gynecol. 74, 502–506 (1989).

    CAS  PubMed  Google Scholar 

  11. Hoffman, D. I., Klove, K. & Lobo, R. A. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil. Steril. 42, 76–81 (1984).

    Article  CAS  Google Scholar 

  12. Young, R. H., Dudley, A. G. & Scully, R. E. Granulosa cell, Sertoli-Leydig cell, and unclassified sex cord-stromal tumors associated with pregnancy: a clinicopathological analysis of thirty-six cases. Gynecol. Oncol. 18, 181–205 (1984).

    Article  CAS  Google Scholar 

  13. Paraskevas, M. & Scully, R. E. Hilus cell tumor of the ovary. A clinicopathological analysis of 12 Reinke crystal-positive and nine crystal-negative cases. Int. J. Gynecol. Pathol. 8, 299–310 (1989).

    Article  CAS  Google Scholar 

  14. Wajchenberg B. L. et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 88, 711–736 (2000).

    Article  CAS  Google Scholar 

  15. Young, R. H. & Scully, R. E. Ovarian steroid cell tumors associated with Cushing's syndrome: a report of three cases. Int. J. Gynecol. Pathol. 6, 40–48 (1987).

    Article  CAS  Google Scholar 

  16. Taylor, N. J. & Moore, N. R. in Clinical Endocrine Oncology (eds Hay, I. D. & Wass, J. A. H) 396–403 (Wiley–Blackwell, Malden, 2008).

  17. Taylor, L., Ayers, J. W., Gross, M. D., Peterson, E. P. & Menon, K. M. Diagnostic considerations in virilization: iodomethyl-norcholesterol scanning in the localization of androgen secreting tumors. Fertil. Steril. 46, 1005–1010 (1986).

    Article  CAS  Google Scholar 

  18. Levens, E. D., Whitcomb, B. W., Csokmay, J. M. & Nieman, L. K. Selective venous sampling for androgen-producing ovarian pathology. Clin. Endocrinol. (Oxf) 70, 606–614 (2009).

    Article  Google Scholar 

  19. Risum, S. et al. The diagnostic value of PET/CT for primary ovarian cancer—a prospective study. Gynecol. Oncol. 105, 145–149 (2007).

    Article  Google Scholar 

  20. Wang, P. H. et al. Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation. Gynecol. Oncol. 83, 596–598 (2001).

    Article  CAS  Google Scholar 

  21. Mattsson, C., Stanhope, C. R., Sam, S. & Young, W. F. Jr. Image in endocrinology: testosterone-secreting ovarian tumor localized with (fluorine-18)-2-deoxyglucose positron emission tomography. J. Clin. Endocrinol. Metab. 91, 738–739 (2006).

    Article  CAS  Google Scholar 

  22. Matuszczyk, A. et al. Leydig cell tumor as a cause of hirsutism in a postmenopausal woman [German]. Med. Klin. 102, 259–262 (2007).

    Article  Google Scholar 

  23. Mavroudis, K., Aloumanis, K., Papapetrou, P. D., Voros, D. & Spanos, I. Virilization caused by an ectopic adrenal tumor located behind the iliopsoas muscle. Fertil. Steril. 87, 1468.e13–1468.e16 (2007).

    Article  Google Scholar 

  24. Hidlebaugh, D. A., Vulgaropulos, S. & Orr, R. K. Treating adnexal masses. Operative laparoscopy vs. laparotomy. J. Reprod. Med. 42, 551–558 (1997).

    CAS  PubMed  Google Scholar 

  25. Medeiros, L.R, Fachel, J. M., Garry, R., Stein A. T. & Furness S. Laparoscopy versus laparotomy for benign ovarian tumours. Cochrane Database of Systematic Reviews, Issue 3, Art. No.: CD004751. doi: 10.1002/14651858.CD004751.pub2 (2005).

  26. Hulka, J. F., Parker, W. H., Surrey, M. W. & Phillips, J. M. Management of ovarian masses. AAGL 1990 survey. J. Reprod. Med. 37, 599–602 (1992).

    CAS  PubMed  Google Scholar 

  27. Fanfani, F. et al. A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. Hum. Reprod. 19, 2367–2371 (2004).

    Article  Google Scholar 

  28. Herrmann, UJ. Sonographic patterns of ovarian tumors. Clin. Obstet. Gynecol. 36, 375–383 (1993).

    Article  CAS  Google Scholar 

  29. Barnor, Q., Kurzawinski T. R. & Conway, S. in Clinical Endocrine Oncology (eds Hay, I. D. & Wass, J. A.H) 390–395 (Wiley–Blackwell, Malden, 2008).

  30. Pascale, M. M. et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin. Endocrinol. (Oxf) 41, 571–576 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Written consent for publication was obtained from the patient. We would like to acknowledge Manuel Faria and Malebranche B. C. da Cunha Neto for kindly reviewing this manuscript and Henrique Moura for gently editing and providing the pathology images.

C. P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Contributions

A. M. Faria, R. V. Perez, J. A. M. Marcondes, D. S. Freire and S. A. Y. Hayashida researched data for the article. A. M. Faria, J. A. M. Marcondes, R. Blasbalg, J. Soares Jr, K. Simões, S. A. Y. Hayashida and M. A. A. Pereira provided a substantial contribution to discussion of the content. A. M. Faria, R. V. Perez, J. A. M. Marcondes, D. S. Freire and K. Simões wrote the article. A. M. Faria, J. A. M. Marcondes and M. A. A. Pereira reviewed/edited the manuscript before submission.

Corresponding author

Correspondence to André M. Faria.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faria, A., Perez, R., Marcondes, J. et al. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor. Nat Rev Endocrinol 7, 240–245 (2011). https://doi.org/10.1038/nrendo.2011.15

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2011.15

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing